Bridgebio Pharma Inc (BBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 681,101 | 405,733 | 547,367 | 475,353 | 392,588 |
| Marketable Securities | N/A | N/A | 39,813 | 44,469 | 58,949 |
| Receivables | 4,722 | 478 | 660 | 235,494 | 1,751 |
| TOTAL | $720,692 | $444,578 | $616,236 | $783,424 | $477,593 |
| Non-Current Assets | |||||
| PPE Net | 7,011 | 8,701 | 9,840 | 11,414 | 11,816 |
| Investments And Advances | 143,747 | 160,443 | 117,006 | 0 | 0 |
| Intangibles | 23,926 | 24,525 | 25,123 | 25,721 | 26,319 |
| Other Non-Current Assets | 23,962 | 26,730 | 26,170 | 28,774 | 30,652 |
| TOTAL | $198,646 | $220,399 | $178,139 | $65,909 | $68,787 |
| Total Assets | $919,338 | $664,977 | $794,375 | $849,333 | $546,380 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 9,618 | 13,363 | 18,126 | 4,728 | 10,655 |
| Accrued Expenses | 92,601 | 109,482 | 96,517 | 118,248 | 122,965 |
| Other current liabilities | 33,071 | N/A | N/A | N/A | N/A |
| TOTAL | $154,400 | $139,216 | $134,364 | $141,477 | $143,844 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,721,382 | 1,719,316 | 1,717,599 | 1,715,932 | 1,726,729 |
| Deferred Revenues | 14,604 | 11,771 | 15,098 | 13,957 | 6,096 |
| Other Non-Current Liabilities | 486,554 | 9,069 | 9,409 | 10,361 | 17,273 |
| TOTAL | $2,222,692 | $1,744,798 | $1,741,881 | $1,745,239 | $1,745,549 |
| Total Liabilities | $2,377,092 | $1,884,014 | $1,876,245 | $1,886,716 | $1,889,393 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 190,189 | 188,990 | 188,033 | 187,129 | 175,832 |
| Common Shares | 196 | 195 | 194 | 193 | 181 |
| Retained earnings | -3,096,263 | -2,831,213 | -2,669,173 | -2,595,717 | -2,560,501 |
| Other shareholders' equity | 10,158 | 10,890 | 11,051 | 12,147 | 11,275 |
| TOTAL | $-1,457,754 | $-1,219,037 | $-1,081,870 | $-1,037,383 | $-1,343,013 |
| Total Liabilities And Equity | $919,338 | $664,977 | $794,375 | $849,333 | $546,380 |